Portfolio Manager Factsheet

July 2015

Healthcare stocks in general rebounded this month after an orderly correction was observed in June. Amgen rose more than 15% after the company posted better than expected second quarter results and raised full year guidance. Biogen dropped by 20% after a poor Q2 report and underwhelming data for its Alzheimer’s compound.

Read more »

Worldwide Healthcare Trust PLC conducts its affairs so that its shares can be recommended by independent financial advisers (IFAs) to retail private investors. The shares are excluded from the Financial Conduct Authority's (FCA's) restrictions which apply to non-mainstream investment products because they are shares in a UK-listed investment trust.